Medicamen Biotech Share Price
318.20-9.85 (-3.00%)
-4.73% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
AUROPHARMANSE
LUPINNSE
DRREDDYNSE
MANKINDNSE
MEDICAMEQ-BENSE
Medicamen Biotech Share Price
318.20-9.85 (-3.00%)
-4.73% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 5% | 12% | -9% |
| - | -13% | -24% | -31% |
| - | - | -22% | -5% |
| 9% | 8% | 6% | 3% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
AUROPHARMA
LUPIN
DRREDDY
MANKIND
MEDICAMEQ-BE
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,868.9 | ₹440398 Cr | 36.41 | 12.07 | 62.82 | ₹11479 Cr |
| 9,410.5 | ₹248664 Cr | 85.01 | 34.04 | 128.41 | ₹2568 Cr |
| 4,970 | ₹182738 Cr | 83.79 | 16.72 | 97.06 | ₹2163 Cr |
| 1,161 | ₹115012 Cr | 25.48 | 9.42 | 62.53 | ₹5040 Cr |
| 1,386.1 | ₹110794 Cr | 32.87 | 9.77 | 57.87 | ₹3879 Cr |
| 2,017.5 | ₹105645 Cr | 96.62 | 6.8 | 29.25 | ₹889 Cr |
| 1,713.4 | ₹99828 Cr | 26.89 | 17.95 | 96.84 | ₹3505 Cr |
| 2,124.5 | ₹98070 Cr | 17.74 | 30.95 | 154.36 | ₹5333 Cr |
| 1,198.3 | ₹97749 Cr | 30.34 | 5.32 | 63.99 | ₹4196 Cr |
| 2,437.8 | ₹95744 Cr | 46.87 | 13.75 | 71.08 | ₹1913 Cr |
| 320.25 | ₹448 Cr | 41.36 | 1.56 | 13.3 | ₹10 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹48 Cr | ₹61 Cr | ₹47 Cr | ₹47 Cr | ₹43 Cr | ₹30 Cr | ₹45 Cr | ₹45 Cr | ₹43 Cr | ₹47 Cr | ₹47 Cr | ₹44 Cr | ₹42 Cr | ₹39 Cr | ₹36 Cr | ₹34 Cr | ₹33 Cr | ₹23 Cr | ₹33 Cr | ₹33 Cr | ₹28 Cr | ₹21 Cr | ₹33 Cr | ₹31 Cr | ₹28 Cr | ₹24 Cr | ₹35 Cr | ₹36 Cr | ₹31 Cr | ₹24 Cr |
| ₹86 L | ₹2 Cr | ₹54 L | ₹37 L | ₹47 L | ₹5 Cr | ₹14 L | ₹29 L | ₹59 L | ₹57 L | ₹83 L | ₹55 L | ₹38 L | ₹35 L | ₹63 L | ₹53 L | ₹96 L | ₹34 L | ₹83 L | ₹48 L | ₹8 L | ₹54 L | ₹10,000 | ₹13 L | ₹8 L | ₹1 Cr | ₹45 L | ₹35 L | ₹4 L | ₹7 L |
| ₹49 Cr | ₹62 Cr | ₹47 Cr | ₹48 Cr | ₹44 Cr | ₹35 Cr | ₹45 Cr | ₹45 Cr | ₹44 Cr | ₹48 Cr | ₹47 Cr | ₹44 Cr | ₹42 Cr | ₹39 Cr | ₹36 Cr | ₹34 Cr | ₹34 Cr | ₹23 Cr | ₹33 Cr | ₹33 Cr | ₹28 Cr | ₹22 Cr | ₹33 Cr | ₹31 Cr | ₹28 Cr | ₹25 Cr | ₹36 Cr | ₹36 Cr | ₹31 Cr | ₹24 Cr |
| ₹45 Cr | ₹57 Cr | ₹44 Cr | ₹44 Cr | ₹40 Cr | ₹32 Cr | ₹41 Cr | ₹42 Cr | ₹41 Cr | ₹43 Cr | ₹43 Cr | ₹41 Cr | ₹37 Cr | ₹34 Cr | ₹31 Cr | ₹29 Cr | ₹29 Cr | ₹19 Cr | ₹28 Cr | ₹28 Cr | ₹23 Cr | ₹17 Cr | ₹28 Cr | ₹26 Cr | ₹24 Cr | ₹21 Cr | ₹31 Cr | ₹30 Cr | ₹27 Cr | ₹20 Cr |
| ₹5 Cr | ₹7 Cr | ₹5 Cr | ₹6 Cr | ₹5 Cr | ₹4 Cr | ₹7 Cr | ₹6 Cr | ₹4 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹5 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹4 Cr | ₹4 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹4 Cr |
| ₹83 L | ₹38 L | ₹97 L | ₹99 L | ₹1 Cr | ₹65 L | ₹76 L | ₹1 Cr | ₹71 L | ₹2 Cr | ₹65 L | ₹91 L | ₹96 L | ₹86 L | ₹68 L | ₹62 L | ₹77 L | ₹56 L | ₹49 L | ₹30 L | ₹4 L | ₹36 L | ₹9 L | ₹38 L | ₹24 L | ₹0 | ₹19 L | ₹21 L | ₹16 L | ₹20 L |
| ₹3 Cr | ₹5 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr |
| ₹2 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹91 L | ₹80 L | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — |
| ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
| ₹0 | ₹0 | ₹3 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹200 Cr | ₹194 Cr | ₹178 Cr | ₹134 Cr | ₹121 Cr | ₹109 Cr | ₹75 Cr |
| ₹200 Cr | ₹194 Cr | ₹178 Cr | ₹134 Cr | ₹121 Cr | ₹109 Cr | ₹75 Cr |
| ₹213 Cr | ₹207 Cr | ₹193 Cr | ₹146 Cr | ₹133 Cr | ₹121 Cr | ₹87 Cr |
| ₹4 Cr | ₹1 Cr | ₹87 L | ₹5 Cr | ₹6 Cr | ₹2 Cr | ₹2 L |
| -₹3 Cr | -₹3 Cr | -₹2 Cr | -₹50 L | ₹28 L | ₹16 L | ₹41 L |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹98 L |
| ₹3 Cr | ₹50 L | ₹65 L | ₹6 Cr | ₹8 Cr | ₹4 Cr | ₹1 Cr |
| — | — | — | — | — | — | — |
| ₹43 Cr | ₹39 Cr | ₹48 Cr | ₹43 Cr | ₹32 Cr | ₹37 Cr | ₹31 Cr |
| ₹1 Cr | ₹11 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹78 L |
| ₹30 Cr | ₹30 Cr | ₹23 Cr | ₹19 Cr | ₹11 Cr | ₹8 Cr | ₹12 Cr |
| ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr |
| ₹78 Cr | ₹85 Cr | ₹83 Cr | ₹73 Cr | ₹53 Cr | ₹56 Cr | ₹49 Cr |
| ₹294 Cr | ₹292 Cr | ₹277 Cr | ₹225 Cr | ₹194 Cr | ₹181 Cr | ₹137 Cr |
| ₹34 Cr | ₹31 Cr | ₹26 Cr | ₹26 Cr | ₹19 Cr | ₹11 Cr | ₹12 Cr |
| — | — | — | — | — | — | — |
| ₹139 Cr | ₹137 Cr | ₹130 Cr | ₹124 Cr | ₹116 Cr | ₹58 Cr | ₹47 Cr |
| ₹52 Cr | ₹45 Cr | ₹38 Cr | ₹32 Cr | ₹26 Cr | ₹24 Cr | ₹22 Cr |
| ₹87 Cr | ₹92 Cr | ₹93 Cr | ₹92 Cr | ₹90 Cr | ₹34 Cr | ₹24 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹40 Cr | ₹15 Cr |
| ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹87 L | ₹78 L | ₹63 L | ₹58 L |
| ₹35 Cr | ₹33 Cr | ₹12 Cr | ₹1 Cr | ₹90 L | ₹29 L | ₹29 L |
| ₹123 Cr | ₹126 Cr | ₹106 Cr | ₹94 Cr | ₹91 Cr | ₹75 Cr | ₹40 Cr |
| — | — | — | — | — | — | — |
| ₹62 Cr | ₹59 Cr | ₹45 Cr | ₹27 Cr | ₹5 Cr | ₹17 Cr | ₹15 Cr |
| ₹69 Cr | ₹55 Cr | ₹65 Cr | ₹63 Cr | ₹53 Cr | ₹50 Cr | ₹43 Cr |
| ₹4 Cr | ₹15 Cr | ₹21 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹9 Cr |
| ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹20 Cr | ₹23 Cr | ₹22 Cr | ₹15 Cr |
| ₹27 Cr | ₹28 Cr | ₹30 Cr | ₹9 Cr | ₹11 Cr | ₹13 Cr | ₹14 Cr |
| ₹165 Cr | ₹160 Cr | ₹163 Cr | ₹123 Cr | ₹96 Cr | ₹104 Cr | ₹96 Cr |
| ₹86 Cr | ₹75 Cr | ₹81 Cr | ₹50 Cr | ₹43 Cr | ₹48 Cr | ₹48 Cr |
| ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹8 Cr | ₹7 Cr | ₹2 Cr | ₹42 L |
| ₹294 Cr | ₹292 Cr | ₹277 Cr | ₹225 Cr | ₹194 Cr | ₹181 Cr | ₹137 Cr |
| ₹162 | ₹158 | ₹145 | ₹114 | ₹103 | ₹98 | ₹74 |
| ₹162 | ₹158 | ₹145 | ₹114 | ₹103 | ₹98 | ₹74 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
| ₹10 Cr | ₹13 Cr | ₹17 Cr | ₹18 Cr | ₹16 Cr | ₹18 Cr | ₹17 Cr |
| ₹10 Cr | ₹11 Cr | ₹9 Cr | ₹7 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
| -₹26 Cr | -₹28 Cr | -₹29 Cr | -₹18 Cr | -₹3 Cr | -₹4 Cr | -₹11 Cr |
| -₹7 Cr | -₹4 Cr | -₹3 Cr | ₹7 Cr | ₹17 Cr | ₹17 Cr | ₹8 Cr |
| -₹8 Cr | -₹7 Cr | -₹6 Cr | ₹4 Cr | ₹13 Cr | ₹13 Cr | ₹4 Cr |
| -₹1 Cr | -₹6 Cr | -₹6 Cr | -₹8 Cr | -₹18 Cr | -₹37 Cr | -₹15 Cr |
| -₹1 Cr | ₹6 Cr | ₹29 Cr | ₹4 Cr | ₹6 Cr | ₹19 Cr | -₹4 Cr |
| -₹11 Cr | -₹6 Cr | ₹17 Cr | -₹7 L | ₹80 L | -₹5 Cr | -₹14 Cr |
| ₹15 Cr | ₹21 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹9 Cr | ₹23 Cr |
| ₹4 Cr | ₹15 Cr | ₹21 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹9 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Medicamen Biotech Share Price
318.20-9.85 (-3.00%)
-4.73% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 2 out of 9 oscillators
RSI
63.08Buy
STOCH %K
56.85Neutral
MACD Level(12,26)
23.74Buy
Ultimate Oscillator
51.59Buy
Aroon Oscillator
44.00Sell
BOP
-0.36Sell
CCI
82.40Neutral
Williams %R
-43.15Neutral
Momentum
56.73Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 8
Bearish signals: 1 out of 9 moving averages
EMA 9
316.94Buy
SMA 9
320.61Sell
EMA 21
292.64Buy
SMA 21
282.13Buy
EMA 50
269.76Buy
SMA 50
256.55Buy
EMA 200
290.04Buy
SMA 200
290.53Buy
WMA 20
303.39Buy
Pivot
Pivot
Classic
Resistance 5
400.20
Resistance 4
383.55
Resistance 3
366.90
Resistance 2
350.25
Resistance 1
339.15
Pivot
333.60
Support 1
322.50
Support 2
316.95
Support 3
300.30
Support 4
283.65
Support 5
267.00
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Medicamen Biotech Share Price
318.20-9.85 (-3.00%)
-4.73% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 40.46% | 40.46% | 40.46% | 40.46% | 40.46% | 43.16% |
| 0.07% | 0.10% | 0.02% | 0.05% | 0.00% | 0.12% |
| 0.40% | 0.00% | 0.44% | 0.59% | 0.64% | 0.69% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 59.07% | 59.44% | 59.08% | 58.90% | 58.90% | 56.03% |
Bulk & block deals
Name
Shivalik Rasayan Limited
Growel Remedies Limited
Jmp Securities Pvt Ltd
Jmp Securities Pvt Ltd
Medicamen Canada Inc
Visionstar
Bp Fintrade Private Limited
Bp Fintrade Private Limited
Rajasthan Global Securities Private Limited
Geometric Securities & Advisory P Ltd
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 22 Mar 2024 | Purchase | 8.44 Cr | ₹421.86 | 2 L | Bulk | 1.474426 | NSE |
| 22 Mar 2024 | Sell | 8.44 Cr | ₹421.86 | 2 L | Bulk | 1.474426 | NSE |
| 16 Nov 2016 | Purchase | 1.38 Cr | ₹250.96 | 55.01 K | Bulk | 0.405548 | BSE |
| 16 Nov 2016 | Sell | 1.36 Cr | ₹252.11 | 53.81 K | Bulk | 0.396702 | BSE |
| 01 Mar 2016 | Sell | 61.71 L | ₹44.08 | 1.40 L | Bulk | 1.032098 | BSE |
| 07 Jan 2016 | Purchase | 38.26 L | ₹76.51 | 50 K | Bulk | 0.368607 | BSE |
| 07 Jan 2016 | Purchase | 17.02 L | ₹77.30 | 22.01 K | Bulk | 0.162275 | BSE |
| 07 Jan 2016 | Sell | 40.19 L | ₹76.83 | 52.31 K | Bulk | 0.385607 | BSE |
| 16 Nov 2015 | Purchase | 17.31 L | ₹35.70 | 48.50 K | Bulk | 0.357534 | BSE |
| 16 Nov 2015 | Sell | 18.27 L | ₹35.70 | 51.19 K | Bulk | 0.377379 | BSE |
Insider trading & SAST
Client name
Sanjay Bansal
Shivalik Rasayan Ltd & Pacs
Shivalik Rasayan Limited
Geetika Madan
Geetika Madan
Geetika Madan
Geetika Madan
Geetika Madan
Growel Remedies Ltd
Geetika Madan
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 Sep 2025 | Director | Disposal | 0.737213 | 0.76 | 0 | — | 1 L | 23 Sep 2025 | Gift | 1,02,813 | Insider Trading | — | Equity Shares |
| 07 May 2025 | Promoter | Acquisition | 0.15 | 40.46 | 0 | — | 21 K | 21 Mar 2025 - 24 Apr 2025 | Market | 54,87,095 | SAST | 29(2) | — |
| 22 Mar 2025 | Promoter | Acquisition | 0.165164 | 43.16 | 1.04 Cr | ₹494.14 | 21 K | 21 Mar 2025 | Market Purchase | 54,87,095 | Insider Trading | — | Equity Shares |
| 17 Dec 2024 | Connected Person | Disposal | 0.002462 | 0.21 | 1.92 L | ₹612.17 | 313 | 06 Dec 2024 | Market Sale | 26,687 | Insider Trading | — | Equity Shares |
| 17 Dec 2024 | Connected Person | Disposal | 0.023595 | 0.21 | 13.46 L | ₹448.65 | 3 K | 25 Nov 2024 | Market Sale | 27,000 | Insider Trading | — | Equity Shares |
| 17 Dec 2024 | Connected Person | Disposal | 0.01573 | 0.19 | 11.45 L | ₹572.29 | 2 K | 12 Dec 2024 | Market Sale | 24,687 | Insider Trading | — | Equity Shares |
| 18 Sep 2024 | Connected Person | Disposal | 0.007865 | 0.24 | 3.98 L | ₹398.20 | 1 K | 20 Aug 2024 | Market Sale | 31,490 | Insider Trading | — | Equity Shares |
| 18 Sep 2024 | Connected Person | Disposal | 0.011719 | 0.23 | 7.09 L | ₹475.86 | 1.49 K | 16 Sep 2024 | Market Sale | 30,000 | Insider Trading | — | Equity Shares |
| 05 Apr 2024 | Promoter | Disposal | 1.57 | — | 0 | — | 2 L | 22 Mar 2024 | Market | — | SAST | 29(2) | — |
| 26 Mar 2024 | Connected Person | Disposal | 0.019261 | 0.27 | 10.48 L | ₹428.07 | 2.45 K | 22 Mar 2024 | Market Sale | 34,490 | Insider Trading | — | Equity Shares |
Medicamen Biotech Share Price
318.20-9.85 (-3.00%)
-4.73% past 1 Year
Medicamen Biotech Limited is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. It is a manufacturer and supplier of a range of products such as
Corporate Actions
Date
Type
Details
Company details
Medicamen Biotech Share Price
318.20-9.85 (-3.00%)
-4.73% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Medicamen Biotech Share Price
318.20-9.85 (-3.00%)
-4.73% past 1 Year
News
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech reports Profit after tax of 2.97 Crores, in the March 2026 quarter
Equity
MEDICAMEQ
Medicamen Biotech informs about board meeting
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech reports Profit after tax of 2.59 Crores, in the December 2025 quarter
Equity
MEDICAMEQ
Medicamen Biotech Q2 FY26 net profit dips marginally, revenue and EBITDA decline YoY.
Equity
MEDICAMEQ
Medicamen Biotech reports Profit after tax of 2.21 Crores, in the September 2025 quarter
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech reports Profit after tax of 1.64 Crores, in the June 2025 quarter
Equity
MEDICAMEQ
Medicamen Biotech gets USFDA’s approval for Bortezomib for injection
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech reports Profit after tax of 2.41 Crores, in the March 2025 quarter
Equity
MEDICAMEQ
Medicamen Biotech signs contract for CDMO with XGX pharma
Equity
MEDICAMEQ
Medicamen Biotech informs about closure of trading window
Equity
MEDICAMEQ
Medicamen Biotech informs about disclosure
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ
Medicamen Biotech - Quaterly Results
Equity
MEDICAMEQ